| Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: a worldwide study JP Arab, LA Díaz, N Baeza, F Idalsoaga, E Fuentes-López, J Arnold, ... Journal of hepatology 75 (5), 1026-1033, 2021 | 67 | 2021 |
| Alcohol consumption: medical implications, the liver and beyond V Meza, J Arnold, LA Díaz, M Ayala Valverde, F Idalsoaga, G Ayares, ... Alcohol and Alcoholism 57 (3), 283-291, 2022 | 34 | 2022 |
| Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles I Martínez‐Arranz, C Bruzzone, M Noureddin, R Gil‐Redondo, I Mincholé, ... Hepatology 76 (4), 1121-1134, 2022 | 31 | 2022 |
| The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas LA Díaz, E Fuentes-López, G Ayares, F Idalsoaga, J Arnold, ... The Lancet Gastroenterology & Hepatology 7 (6), 552-559, 2022 | 30 | 2022 |
| Current medical treatment for alcohol-associated liver disease G Ayares, F Idalsoaga, LA Díaz, J Arnold, JP Arab Journal of Clinical and Experimental Hepatology 12 (5), 1333-1348, 2022 | 25 | 2022 |
| Liver diseases in Latin America: current status, unmet needs, and opportunities for improvement LA Díaz, G Ayares, J Arnold, F Idalsoaga, O Corsi, M Arrese, JP Arab Current Treatment Options in Gastroenterology 20 (3), 261-278, 2022 | 20 | 2022 |
| Public health measures and prevention of alcohol-associated liver disease G Ayares, F Idalsoaga, J Arnold, E Fuentes-López, JP Arab, LA Díaz Journal of Clinical and Experimental Hepatology 12 (6), 1480-1491, 2022 | 18 | 2022 |
| The mortality index for alcohol-associated hepatitis: a novel prognostic score CA Kezer, SM Buryska, JC Ahn, WS Harmsen, W Dunn, AK Singal, ... Mayo Clinic Proceedings 97 (3), 480-490, 2022 | 10 | 2022 |
| Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes LA Díaz, E Fuentes-López, F Idalsoaga, G Ayares, O Corsi, J Arnold, ... Journal of Hepatology 80 (3), 409-418, 2024 | 9 | 2024 |
| Prevalence of Helicobacter pylori antimicrobial resistance among Chilean patients P González-Hormazábal, A Arenas, C Serrano, M Pizarro, ... Archives of medical research 52 (5), 529-534, 2021 | 7 | 2021 |
| Eventos adversos asociados al uso de inhibidores de bomba de protones: un análisis crítico de la evidencia actual J Arnold, K Bruning, A Riquelme, JI Vargas Gastroenterol. latinoam 29 (2), 61-8, 2018 | 7 | 2018 |
| MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis LA Díaz, E Fuentes-López, G Ayares, F Idalsoaga, J Arnold, MA Valverde, ... JHEP Reports 5 (8), 100727, 2023 | 5 | 2023 |
| Current and emerging therapies for alcohol-associated hepatitis F Idalsoaga, G Ayares, LA Díaz, J Arnold, M Ayala-Valverde, D Hudson, ... Liver Research, 2023 | 4 | 2023 |
| Diagnóstico de divertículo de Meckel mediante cápsula endoscópica SG Latorre, LJ Gómez, AJ Arnold, PF Silva, RF Bellolio, LJ Escarate, ... Rev Gastroenterol Latinoam Pontif Univ Católica Chile [Internet] 32 (1), 14-7, 2021 | 4 | 2021 |
| Pancreatitis aguda por hipercalcemia en el embarazo. Caso clínico J Arnold, W Martínez, S Oksenberg, D Oksenberg Revista médica de Chile 147 (8), 1078-1081, 2019 | 3 | 2019 |
| Emerging Drug Therapies for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Glimpse into the Horizon J Arnold, F Idalsoaga, LA Díaz, D Cabrera, F Barrera, JP Arab, M Arrese Current Hepatology Reports, 1-16, 2024 | 2 | 2024 |
| Development and validation of nonalcoholic fatty liver disease test: a simple sensitive and specific marker for early diagnosis of nonalcoholic fatty liver disease M Omran, M Omr, AA Mohamed, RA Abdelghafour, NM Muharram, ... European journal of gastroenterology & hepatology 35 (8), 874-880, 2023 | 1 | 2023 |
| OP-5 alcohol-associated hepatitis in Latin America: Results from the AH-Latin study LA Díaz, J Arnold, F Idalsoaga, G Ayares, M Ayala-Valverde, D Perez, ... Ann Hepatol 28, 101054, 2023 | 1 | 2023 |
| Nutrition in Alcohol-Related Liver Disease M Ayala-Valverde, J Arnold, LA Díaz, F Idalsoaga, M Arrese, JP Arab Current Hepatology Reports 21 (4), 111-119, 2022 | 1 | 2022 |
| An Artificial Intelligence-Generated Model From A Global Cohort To Predict 90-Day Survival In Alcohol-Associated Hepatitis W Dunn, Y Li, AK Singal, DA Simonetto, L Antonio Diaz, ... Hepatology 76, S112-S113, 2022 | 1 | 2022 |
Juan Pablo Arab, MDAssociate Professor of Medicine, Western University, London, ON, CanadaVerified email at uwo.ca
